• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 3 filed by new insider Hutton Michael

    3/18/26 9:19:25 PM ET
    $MBAI
    Medical Electronics
    Health Care
    Get the next $MBAI alert in real time by email
    SEC FORM 3SEC Form 3
    FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number:3235-0104
    Estimated average burden
    hours per response:0.5
    1. Name and Address of Reporting Person*
    Hutton Michael

    (Last)(First)(Middle)
    ABBA HUSHI AVENUE
    P.O. BOX 1271

    (Street)
    ISFIYAMOUNT CARMEL30090

    (City)(State)(Zip)

    ISRAEL

    (Country)
    2. Date of Event Requiring Statement (Month/Day/Year)
    03/18/2026
    3. Issuer Name and Ticker or Trading Symbol
    Check-Cap Ltd [ MBAI ]
    3a. Foreign Trading Symbol
    [MBAI]
    5. If Amendment, Date of Original Filed (Month/Day/Year)
    4. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    XDirector10% Owner
    Officer (give title below)Other (specify below)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    XForm filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Beneficially Owned
    1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
    Table II - Derivative Securities Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
    Date ExercisableExpiration DateTitleAmount or Number of Shares
    Explanation of Responses:
    No securities are beneficially owned.
    /s/ Michael Hutton03/18/2026
    ** Signature of Reporting PersonDate
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    * Form 3: SEC 1473 (03-26)
    Get the next $MBAI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MBAI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $MBAI
    SEC Filings

    View All

    SEC Form 6-K filed by Check-Cap Ltd.

    6-K - Check-Cap Ltd (0001610590) (Filer)

    3/31/26 8:35:23 AM ET
    $MBAI
    Medical Electronics
    Health Care

    SEC Form 424B3 filed by Check-Cap Ltd.

    424B3 - Check-Cap Ltd (0001610590) (Filer)

    2/24/26 9:05:00 AM ET
    $MBAI
    Medical Electronics
    Health Care

    SEC Form 6-K filed by Check-Cap Ltd.

    6-K - Check-Cap Ltd (0001610590) (Filer)

    2/24/26 9:02:58 AM ET
    $MBAI
    Medical Electronics
    Health Care

    $MBAI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Cheung Carlos

    3 - Check-Cap Ltd (0001610590) (Issuer)

    3/20/26 4:15:06 PM ET
    $MBAI
    Medical Electronics
    Health Care

    SEC Form 3 filed by new insider Kokiw Daniel

    3 - Check-Cap Ltd (0001610590) (Issuer)

    3/18/26 9:21:37 PM ET
    $MBAI
    Medical Electronics
    Health Care

    SEC Form 3 filed by new insider Lewis Alan D.

    3 - Check-Cap Ltd (0001610590) (Issuer)

    3/18/26 9:20:50 PM ET
    $MBAI
    Medical Electronics
    Health Care

    $MBAI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    MBody AI and Check Cap Ltd. ($MBAI) Submit Nasdaq Listing Application for Merger Close

    ISFIYA, Israel, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Check-Cap Ltd. (NASDAQ:MBAI) ("Check-Cap" or the "Company"), a Nasdaq-listed company, today announced that MBody AI Corp. ("MBody AI") has submitted its Nasdaq listing application, representing a significant regulatory milestone toward closing the previously announced merger between Check-Cap and MBody AI. The submission of the application further advances the prospective combined company toward its anticipated Nasdaq Capital Markets ("Nasdaq") listing, targeted for the first half of 2026, subject to customary closing conditions. The Nasdaq application submission follows a series of significant milestones achieved in recent months, i

    2/24/26 8:35:00 AM ET
    $MBAI
    Medical Electronics
    Health Care

    Check-Cap Advances MBody AI Merger with F-1 Filing and MBody AI Audited Financials

    ISFIYA, Israel, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Check-Cap Ltd. (NASDAQ:MBAI) ("Check-Cap" or the "Company") today announced key regulatory milestones supporting the completion of its previously announced merger with MBody AI Corp. ("MBody AI"), the filing of a Form F-1 Registration Statement and the furnishing of MBody AI's audited financial statements on Form 6-K. These filings follow the Company's return to compliance with Nasdaq continued listing requirements and represent significant steps toward closing the merger in the first half of 2026. F-1 Filing Supports Strategic Capital Flexibility The Form F-1 registers shares in connection with Check-Cap's previously announced equity

    2/2/26 8:35:00 AM ET
    $MBAI
    Medical Electronics
    Health Care

    Check-Cap Clears Key Nasdaq Requirement, Advancing MBody AI Merger Toward Completion

    ISFIYA, Israel, Jan. 26, 2026 (GLOBE NEWSWIRE) -- Check-Cap Ltd. (NASDAQ:MBAI) ("Check-Cap" or the "Company") today announced that it has received written confirmation from the Nasdaq Listing Qualifications Department that the Company has regained compliance with Nasdaq's minimum shareholders' equity requirements pursuant to Nasdaq Listing Rule 5550(b). This confirmation clears a key regulatory requirement and represents a significant positive milestone as Check-Cap advances toward completion of its previously announced, shareholder-approved merger with MBody AI. The merger is expected to transform Check-Cap into a publicly traded leader in embodied artificial intelligence, subject to c

    1/26/26 9:50:00 AM ET
    $MBAI
    Medical Electronics
    Health Care